Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory, Randomized, Multicenter, Open-Label, Controlled, Parallel-Group Clinical Study to Evaluate the Efficacy of Papilozumib® Vaginal Gel in the Restoration of the Exocervical Mucosa

NCT07762209 is registered in ClinicalTrials.gov with Hifas da Terra S.L. as lead sponsor.

NCT NCT07762209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07762209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory, Randomized, Multicenter, Open-Label, Controlled, Parallel-Group Clinical Study to Evaluate the Efficacy of Papilozumib® Vaginal Gel in the Restoration of the Exocervical Mucosa
Lead sponsor
Hifas da Terra S.L.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 31, 2027
Completion date
December 31, 2027
Enrollment
81 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

human papillomavirus infection, human papillomavirus infections